theoncologist.alphamedpress.org
Critical review of treatments for advanced, metastatic melanoma to determine success of current and the promise of emerging therapies. [2011]
URLs from theoncologist.alphamedpress.org:
URL: http://theoncologist.alphamedpress.org/cgi/content/full/11/1/65 URL: http://theoncologist.alphamedpress.org/content/16/1/5.full URL: http://theoncologist.alphamedpress.orgTweets about theoncologist.alphamedpress.org
- @NirajGusani #PancSM recent paper in Oncologist was enlightening:
- RT @drdonsdizon: A very personal #Narrative about my dad's journey @EOL. So grateful that @OncJournal published it. …
- RT @pfanderson: SPIKES—A Six-Step Protocol for Delivering Bad News: Application to the Patient with Cancer #hcsm #bi…
- SPIKES—A Six-Step Protocol for Delivering Bad News: Application to the Patient with Cancer #hcsm #bioethx #hcldr
- THEONCOLOGIST : The Oncologist Things look grim for #RobFord. Perhaps is actions reflect "We who are about to die. .
- 10.3 mo $MACK
- @PinkyG123 6.1 mos MOS for 3 parts of Folfirinox?1.9 mos better than 2 - MM398 Alone Higher AE's- Heres 10.3 mo $HALO
- 10.3 Mo. MOS in Same Setting - $BAX paid $970M for MACK's 6.1 Circa 2001-Gem alone is old standard Folf or G-A now
- Irinotecan,Gemcitabine, 5-Fluorouracil, Leucovorin, Cisplatin-Same Setting as $MACK BUT 10.3 mo MOS not 6.1-no nano
- RT @HarvardHGEI: Now in The @OncJournal Gr8 Article on Evaluation of Breast Cancer Knowledge in #Mexico @harreolao @FeliciaKnaul
- Now in The @OncJournal Gr8 Article on Evaluation of Breast Cancer Knowledge in #Mexico @harreolao @FeliciaKnaul
- RT @tomateloapecho: La capacitación focalizada a promotores de la salud mejora conocimientos de #cáncerdemama y duran por varios meses http…
- La capacitación focalizada a promotores de la salud mejora conocimientos de #cáncerdemama y duran por varios meses